Cas:50503-42-9 4,6-dimethoxypyridin-3-amine,dihydrochloride manufacturer & supplier

Chemical Name:4,6-dimethoxypyridin-3-amine,dihydrochloride

CAS.NO:50503-42-9

Synonyms:4,6-DIMETHOXY-PYRIDIN-3-YLAMINE DIHYDROCHLORIDE;4,6-Dimethoxypyridin-3-amine dihydrochloride

Molecular Formula:C₇H₁₂Cl₂N₂O₂

Molecular Weight:227.08800

HS Code:2933399090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:57.37000

Exact Mass:226.02800

LogP:2.86620

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 4,6-DIMETHOXY-PYRIDIN-3-YLAMINE DIHYDROCHLORIDE chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4,6-Dimethoxypyridin-3-amine dihydrochloride physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4,6-Dimethoxypyridin-3-amine dihydrochloride Use and application,4,6-DIMETHOXY-PYRIDIN-3-YLAMINE DIHYDROCHLORIDE technical grade,usp/ep/jp grade.

Related News: The quality of the drug substance determines the quality of the preparation, so its quality standards are very strict. Countries around the world have formulated strict national pharmacopoeia standards and quality control methods for their widely used drug substances. 4,6-dimethoxypyridin-3-amine,dihydrochloride manufacturer The vaccine also proved safe during the two-year trial, in which eleven doses were administered to randomly chosen patients with mild dementia. People who received the vaccine, known as AADvac1, experienced about the same numbers of side effects and adverse events as those who were given a placebo. 4,6-dimethoxypyridin-3-amine,dihydrochloride supplier The quality of the drug substance determines the quality of the preparation, so its quality standards are very strict. Countries around the world have formulated strict national pharmacopoeia standards and quality control methods for their widely used drug substances. 4,6-dimethoxypyridin-3-amine,dihydrochloride vendor For Jefferies, this “has not been demonstrated to convincingly reduce Abeta plaque burden, in our view.” The firm forecasts $3 billion in global sales for gantenerumab, but at a striking 0%, “so probability so no contribution.” 4,6-dimethoxypyridin-3-amine,dihydrochloride factory The vaccine also proved safe during the two-year trial, in which eleven doses were administered to randomly chosen patients with mild dementia. People who received the vaccine, known as AADvac1, experienced about the same numbers of side effects and adverse events as those who were given a placebo.